Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease.
about
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World PerspectiveEstimating intracardiac and extracardiac shunting in the setting of complex congenital heart diseaseConsensus conference on the appropriateness of palivizumab prophylaxis in respiratory syncytial virus disease.Retrospective Multicenter Study of Respiratory Syncytial Virus Prophylaxis in Korean Children with Congenital Heart Diseases.Respiratory syncytial virus--a comprehensive review.Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations.Prevention and prophylaxis of respiratory syncytial virus in pediatric cardiology: a UK perspective.CHD and respiratory syncytial virus: global expert exchange recommendations.Incidence of Respiratory Disease During the First Two Years of Life in Children with Hemodynamically Significant Congenital Heart Disease in Italy: A Retrospective Study.Respiratory syncytial virus prophylaxis in children with cardiac disease: a retrospective single-centre study.Respiratory Tract Infection and Risk of Hospitalization in Children with Congenital Heart Defects During Season and Off-Season: A Swedish National Study.Efficacy of palivizumab prophylaxis among infants with congenital heart disease: A case control study.Evaluating national guidelines for the prophylactic treatment of respiratory syncytial virus in children with congenital heart disease.
P2860
Q26830864-B056BA6C-9FDA-4AD8-80DF-C007FF0C5E5DQ27014869-1565B458-41EE-402F-BFDA-D17DAEC4D77FQ30245434-4A589AB1-F778-4533-8EF0-4B860B316D03Q37318542-16E1227F-D4CB-4E28-9BCC-361592F9B12BQ38098094-F16CB6E2-B80C-463A-AA1C-F8FCB3C529F4Q38198120-552CAA55-C4E7-42F9-A8B0-7D9A1F1B789FQ38206841-497CCF8D-AA8B-4D88-860C-A3943589B2B6Q38723728-0530340D-5822-43C1-B811-C67FE4653EF3Q39442518-6CBA0186-59BB-4555-91B7-B9E4A3AC1D3EQ40249493-479C3E35-9D76-46A4-A4A6-47BF334A9677Q40709529-CE5DFDA1-BC95-4C6B-B81E-4E9F27B85933Q42197941-11A8762F-7739-42B8-BC45-4B8A2308E8ABQ42225156-8AF6867F-9BA5-4A8F-BCC4-368AFAD443EE
P2860
Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease.
@en
Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease.
@nl
type
label
Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease.
@en
Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease.
@nl
prefLabel
Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease.
@en
Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease.
@nl
P2093
P2860
P1476
Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease.
@en
P2093
Andrew J Daley
Daniel J Penny
Jenny Royle
Lara S Shekerdemian
Lucas Eastaugh
Peta M A Alexander
P2860
P304
P356
10.1111/J.1440-1754.2011.02219.X
P577
2012-05-01T00:00:00Z